A32 Evaluation of the Mutant KRAS-Driven NSCLC Tumor Immune Microenvironment Using Patient-Derived Cell Line Xenografts in a Humanized Mouse Preclinical Model for Development of New Immunotherapy Approaches

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 15; no. 2; p. S23
Main Authors Li, H., Han, C., Park, H., Zhang, A., Liu, Z., Girard, L., Sorrelle, N., Brekken, R.A., Fu, Y., Minna, J.D.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.02.2020
Online AccessGet full text

Cover

More Information
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2019.12.061